Merck & Co. Inc. buy Argus
Start price
07.06.24
/
50%
€119.60
Target price
07.06.25
-
Performance (%)
-42.31%
End price
08.06.25
€69.00
Summary
This prediction ended on 08.06.25 with a price of €69.00. Massive losses of -42.31% were the result for the BUY prediction by Argus. Dividends of €2.99 are taken into consideration when calculating the performance. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | -1.848% | -1.848% | 57.235% |
| iShares Core DAX® | 3,90 % | 2,67 % | 5,69 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % | 19,50 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % | 46,05 % |
| iShares S&P 500 | -0,88 % | -1,49 % | 16,91 % |
Comments by Argus for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at Argus to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Argus gewählte maximale Laufzeit wurde überschritten